Clark Estates Inc. NY Purchases Shares of 27,000 Amdocs Limited $DOX

Clark Estates Inc. NY acquired a new position in shares of Amdocs Limited (NASDAQ:DOX) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 27,000 shares of the technology company’s stock, valued at approximately $2,215,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Pzena Investment Management LLC boosted its position in Amdocs by 0.6% during the 3rd quarter. Pzena Investment Management LLC now owns 6,593,249 shares of the technology company’s stock worth $540,976,000 after purchasing an additional 42,184 shares during the period. LSV Asset Management lifted its stake in shares of Amdocs by 7.6% during the third quarter. LSV Asset Management now owns 3,648,703 shares of the technology company’s stock worth $299,376,000 after purchasing an additional 257,193 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its position in shares of Amdocs by 3.0% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,111,312 shares of the technology company’s stock worth $252,856,000 after buying an additional 91,428 shares during the period. Vanguard Group Inc. grew its stake in shares of Amdocs by 0.3% in the third quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock valued at $251,602,000 after buying an additional 9,207 shares in the last quarter. Finally, Brandes Investment Partners LP raised its holdings in shares of Amdocs by 1.2% during the 2nd quarter. Brandes Investment Partners LP now owns 2,328,804 shares of the technology company’s stock valued at $212,481,000 after buying an additional 27,581 shares during the period. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Stock Performance

Shares of DOX stock opened at $70.17 on Monday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06. The stock has a market capitalization of $7.57 billion, a price-to-earnings ratio of 13.57, a PEG ratio of 1.25 and a beta of 0.40. Amdocs Limited has a one year low of $66.53 and a one year high of $95.41. The company’s 50-day simple moving average is $78.78 and its 200-day simple moving average is $81.17.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.06. The firm had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.15 billion. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.Amdocs’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.66 earnings per share. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Equities analysts anticipate that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Tuesday, March 31st will be issued a $0.569 dividend. This is a boost from Amdocs’s previous quarterly dividend of $0.53. This represents a $2.28 dividend on an annualized basis and a yield of 3.2%. The ex-dividend date of this dividend is Tuesday, March 31st. Amdocs’s dividend payout ratio is presently 40.81%.

Analyst Upgrades and Downgrades

DOX has been the subject of several recent research reports. Stifel Nicolaus lowered their price objective on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Wall Street Zen raised shares of Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a report on Tuesday, January 27th. Bank of America cut their price target on Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research note on Wednesday, November 12th. Finally, Wolfe Research restated a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $92.33.

Amdocs Company Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.